Resistin, Visfatin, Adiponectin, and Leptin: Risk of Breast Cancer in Pre- and Postmenopausal Saudi Females and Their Possible Diagnostic and Predictive Implications as Novel Biomarkers
Table 1
The characteristic features, metabolic, and adipokines levels of healthy control and BC group.
Healthy control
Breast cancer
value
( = 68)
( = 82)
Age (years)
52.25 ± 16.62
53.682 ± 13.98
0.567
BMI (kg/m2)
24.84 ± 1.35
24.59 ± 1.48
0.062
WC (cm)
76.34 ± 3.05
77.52 ± 3.34
0.026*
SBP (mmHg)
124.79 ± 9.21
127.52 ± 10.52
0.096
DBP (mmHg)
83.01 ± 7.98
80.85 ± 9.83
0.147
Glucose (mg/dL)
92.42 ± 12.39
94.80 ± 13.51
0.076
TG (mg/dL)
123.38 ± 27.403
152.60 ± 22.60
0.000*
TC (mg/dL)
192.53 ± 17.718
216.52 ± 28.82
0.000*
LDLc (mg/dL)
131.43 ± 23.29
145.06 ± 21.32
0.000*
HDLc (mg/dL)
45.47 ± 5.41
40.36 ± 4.38
0.000*
Leptin (ng/mL)
19.62 ± 2.03
24.59 ± 5.57
0.000*
Adiponectin (mg/L)
10.96 ± 1.60
8.44 ± 2.12
0.000*
Resistin (μg/L)
22.69 ± 2.58
26.24 ± 1.59
0.000*
Visfatin (ng/mL)
15.57 ± 2.41
18.36 ± 3.92
0.000*
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; Tc: total cholesterol; < 0.05.
